文献速递头颈外科

调强放疗联合计划性伽玛刀放射外科推量治疗邻近关键结构的广泛头颈癌

Intensity-modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structures.
PubMed 文献 · Head Neck · 2022-09-01

回顾性分析2011至2021年接受调强放疗联合伽玛刀放射外科推量治疗的20例头颈癌患者,其中19例为T3-4期。中位随访26.3个月,伽玛刀照射部位控制率95%,2年总生存率94.7%(95%CI:85.2%-100%),3例发生脑放射性坏死。结论认为该方案对邻近关键结构的病变控制良好且毒性轻微。

要点

  • 调强放疗联合伽玛刀推量治疗邻近关键结构的头颈癌,伽玛刀部位控制率达95%。
  • 20例患者中19例为T3-4期,2年总生存率为94.7%(95%CI:85.2%-100%)。
  • 3例发生脑放射性坏死,其中1例经活检证实。

核心结论

  • 调强放疗联合伽玛刀放射外科推量治疗邻近关键结构的病变可获得优异的疾病控制,且毒性轻微。

研究设计与样本

  • 回顾性分析2011年至2021年间接受调强放疗联合伽玛刀放射外科推量作为综合治疗一部分的头颈癌患者,共纳入20例。

主要发现

  • 19例患者为T3-4期肿瘤,中位随访26.3个月。
  • 伽玛刀照射部位控制率为95%。
  • 2例在原发治疗部位进展,1例在伽玛刀治疗体积边缘失败,无神经周围或颅内失败。
  • 2年总生存率为94.7%(95%CI:85.2%-100%)。
  • 9例(45%)接受同步化疗,1例(5%)接受诱导/同步化疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To describe intensity-modulated radiotherapy (IMRT) with Gamma Knife Radiosurgery (GKRS) boost for locally advanced head and neck cancer (HNC) with disease near dose-limiting structures. METHODS: Patients with HNC treated with IMRT/GKRS as part of a combined modality approach between 2011 and 2021 were reviewed. Local control, overall survival and disease-specific survival were estimated using the Kaplan Meier method. RESULTS: Twenty patients were included. Nineteen patients had T3-4 tumors. Median follow-up was 26.3 months. GKRS site control was 95%. Two patients progressed at the treated primary site, one patient failed at the edge of the GKRS treatment volume, with no perineural or intracranial failure. 2-year OS was 94.7% (95% CI: 85.2%-100%). Concurrent chemotherapy was given in nine patients (45%). One patient (5%) received induction/concurrent chemotherapy. Brain radionecrosis occurred in three patients, one of which was biopsy-proven. CONCLUSIONS: IMRT plus GKRS boost results in excellent disease control near critical structures with minimal toxicity.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Farris JC, Steber CR, Black PJ, et al. Intensity-modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structures. Head Neck. 2022. PMID: 36047613. doi:10.1002/hed.27176

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。